We are live on ! Find out more
SA

Sovran Advisors Portfolio holdings

AUM $1.34B
1-Year Est. Return 21.63%
This Fund
S&P 500
This Quarter Est. Return
+8.46%
1 Year Est. Return
+21.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.13B
AUM Growth
+$177M
Cap. Flow
+$99.2M
Cap. Flow %
8.76%
Top 10 Hldgs %
19.04%
Holding
555
New
69
Increased
253
Reduced
186
Closed
36

Sector Composition

Rank Sector Weight
1 Miscellaneous 71.99%
2 Technology 10.61%
3 Healthcare 3.62%
4 Financials 3.32%
5 Consumer Discretionary 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAST icon
301
Fastenal
FAST
$57.1B
$595K 0.05%
14,324
-3,914
-21% -$185K
SCHZ icon
302
Schwab US Aggregate Bond ETF
SCHZ
$10.6B
$587K 0.05%
24,942
+1,466
+6% +$34.1K
BEN icon
303
Franklin Templeton
BEN
$17.6B
$586K 0.05%
25,753
+343
+1% +$8.48K
EEM icon
304
iShares MSCI Emerging Markets ETF
EEM
$31.2B
$586K 0.05%
10,572
+2,868
+37% +$144K
XLG icon
305
Invesco S&P 500 Top 50 ETF
XLG
$11B
$578K 0.05%
9,692
+5,434
+128% +$297K
GDXY
306
YieldMax Gold Miners Option Income Strategy ETF
GDXY
$297M
$576K 0.05%
36,906
-594
-2% -$9.29K
BAC icon
307
Bank of America
BAC
$436B
$573K 0.05%
10,809
+557
+5% +$27.2K
GEV icon
308
GE Vernova
GEV
$243B
$572K 0.05%
996
+120
+14% +$72.7K
PRF icon
309
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
$572K 0.05%
12,540
-413
-3% -$18K
RCL icon
310
Royal Caribbean
RCL
$74.7B
$565K 0.05%
1,987
MNST icon
311
Monster Beverage
MNST
$91.8B
$565K 0.05%
16,966
+4,220
+33% +$132K
ITOT icon
312
iShares Core S&P Total US Stock Market ETF
ITOT
$97.4B
$563K 0.05%
3,797
+1,586
+72% +$222K
DFIV icon
313
Dimensional International Value ETF
DFIV
$21.9B
$561K 0.05%
+12,075
New +$540K
HON icon
314
Honeywell
HON
$68.9B
$560K 0.05%
2,970
+676
+29% +$141K
SCHG icon
315
Schwab US Large-Cap Growth ETF
SCHG
$63.1B
$559K 0.05%
+16,848
New +$513K
VRTX icon
316
Vertex Pharmaceuticals
VRTX
$137B
$558K 0.05%
1,328
-57
-4% -$23.8K
AMAT icon
317
Applied Materials
AMAT
$366B
$558K 0.05%
2,397
-922
-28% -$167K
IVOV icon
318
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.34B
$553K 0.05%
5,596
-102
-2% -$10.1K
PCM
319
PCM Fund
PCM
$66.7M
$553K 0.05%
88,609
+3,354
+4% +$21.5K
QYLD icon
320
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.34B
$551K 0.05%
31,611
-5,590
-15% -$93.9K
SPYG icon
321
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.6B
$538K 0.05%
4,994
-617
-11% -$61.5K
FCOM icon
322
Fidelity MSCI Communication Services Index ETF
FCOM
$1.79B
$536K 0.05%
7,606
+1,350
+22% +$91.3K
AZO icon
323
AutoZone
AZO
$48.4B
$534K 0.05%
144
+5
+4% +$20.1K
AMP icon
324
Ameriprise Financial
AMP
$49.4B
$532K 0.05%
1,172
-574
-33% -$294K
XTEN icon
325
BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF
XTEN
$1.05B
$532K 0.05%
11,326
+435
+4% +$20K

Similar funds

Sovran Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Sovran Advisors held 555 positions worth $1.13B, up 19% from $954M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Sovran Advisors deployed $99.2M of net new capital in Q3 2025, opening 69 new positions and adding to 253 existing holdings. Its largest new stake was BitMine Immersion Technologies: 160,057 shares worth $7.13M.

By sector, the portfolio is most concentrated in Miscellaneous at 72% of assets, down from 73% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $8.35M trimmed.

  • Sovran Advisors's largest Q3 2025 buy was BitMine Immersion Technologies: 160,057 shares worth $7.13M.
  • Sovran Advisors added most to BlackRock US Equity Factor Rotation ETF in Q3 2025, an estimated $4.63M increase.
  • Sovran Advisors's biggest Q3 2025 reduction was Ionis Pharmaceuticals, cutting an estimated $8.35M.
  • Sovran Advisors fully exited Summit Therapeutics in Q3 2025, selling an estimated $3.45M.
  • Sovran Advisors's ten largest holdings make up 19% of its $1.13B portfolio in Q3 2025.
  • Sovran Advisors opened 69 new positions and closed 36 in Q3 2025.
  • Sovran Advisors's portfolio value rose 19% quarter-over-quarter to $1.13B.

Based on Sovran Advisors's 13F filing for Q3 2025, filed 31 Oct 2025.